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Background: Psychobiological processes linking stress and vascular diseases remain poorly understood. The retina
and the brain share a common embryonic-diencephalon origin and blood-barrier physiology e.g. ongoing
ischemia facilitates S100B release with astrocytic activity and glial-ﬁbrillary-acidic-protein expression (GFAP).
However, GFAP decreases revealed astrocyte pathology in the prefrontal cortex of depression/suicide cases; and
might be a key mechanism in stress – disease pathways.
Methods: A chronic emotional stress phenotype independent of age, ethnicity or sex was used to stratify the
current prospective cohort (N ¼ 359; aged 46  9 years) into Stress (N ¼ 236) and no-Stress groups (N ¼ 123).
Prospective data for glia ischemia risk markers were obtained, including 24 h BP, fasting S100B, GFAP, HbA1C and
tumor-necrosis-factor-α (TNF-α). At 3-yr follow-up: diastolic-ocular-perfusion-pressure (indicating hypo-perfusion
risk) was measured and retinal vessel calibers were quantiﬁed from digital images in the mydriatic eye.
Results: Higher hypertension (75% vs. 16%), diabetes (13% vs. 0%) and retinopathy (57% vs. 45%) prevalence
was observed in Stress compared to no-Stress individuals. Stressed individuals had consistently raised S100B,
TNF-α, HbA1C and higher diastolic-ocular-perfusion-pressure, but decreases in GFAP and GFAP:S100B. Further-
more stroke risk markers, arterial narrowing and venous widening were associated with consistently raised
S100B, GFAP:S100B (p ¼ 0.060), TNF-α and higher diastolic-ocular-perfusion-pressure [Adj. R2 0.39–0.41, p 
0.05]. No retinal-glia associations were evident in the no-Stress group.
Conclusions: Retinal-glia ischemia and inﬂammation was induced by chronic stress. Persistent higher inﬂamma-
tion and S100B with GFAP decreases further reﬂected stress-induced astrocyte pathology in the human retina. It is
recommended to increase awareness on chronic stress and susceptibility for brain ischemia.
1. Introduction
Emotional stress (coined stress) was associated with sub-clinical
neurovascular dysregulation (Lucassen et al., 2014). Stress indeed facil-
itated astrocytic release of calcium-binding glycoprotein S100B in rodent
models inducing ongoing ischemia (Mathea and Newman, 2006).
Concomitant activation of the hypothalamic-pituitary-adrenal-axis
(HPAA) (Simard et al., 2018; Sild et al., 2017) could therefore link
stress and glial damage induced by ischemia.
Astrocytes are the most abundant glia cells in the central nervous
system (CNS) and communicate with each other through calcium waves,
glial activation, gliotransmitter release and proinﬂammatory cytokine-
induction, e.g. tumor necrosis factor-alpha (TNF-α) (Bender et al.,
2016). Glial-ﬁbrillary-acidic-protein expression (GFAP) is an intermedi-
ate ﬁlament protein and correlate of S100B release (Matias et al., 2019;
Yang and Wang, 2015). GFAP reﬂects astrocyte activation or reactive
astrogliosis (Matias et al., 2019) and acts as a calcium sensor (Yang and
Wang, 2015). Reactive astrogliosis has been related to concomitant
upregulation of GFAP, whereas downregulation was observed in
depression/suicide cases, characterized by a decrease in astrocyte density
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in the prefrontal cortex and amygdala (Torres-Plata et al., 2016).
Ischemic conditions further altered neuron and glia cell signaling in the
retina (Lee and Chung, 2019) and S100B protein was found to be
concentrated in astrocytes of retinal neural layers (Kuehn et al., 2018)
(Fig. 1). Indeed, S100B and GFAP were notably visible in astrocytes and
Müller cells, and more apparent in diabetic patients (Vujosevic et al.,
2015).
Both S100B and GFAP may therefore increase risk for neural damage,
as S100B-intravitreal injections induced ischemia and glaucoma-like
symptoms with early optic nerve axon degeneration followed subse-
quently by retinal damage (Kuehn et al., 2018; Vujosevic et al., 2015;
Hansen et al., 2012). In addition, reduced ocular blood ﬂow to the optic
nerve head is facilitated by higher blood pressure and/or lower
intra-ocular pressure with increases in vascular resistance and ischemia
(Hansen et al., 2012). As diastolic ocular venous pressure is similar or
slightly higher than intraocular pressure, it can be estimated as the dif-
ference between diastolic blood pressure and intra-ocular pressure,
reﬂecting diastolic-ocular-perfusion-pressure, as a marker of
hypo-perfusion (Flammer et al., 2013; Malan et al., 2016a). We therefore
aimed to assess ischemia risk in retinal-glia markers [retinal vessel cali-
bers, diastolic-ocular-perfusion-pressure, TNF-α, and glia cell signaling
(S100B, GFAP)] in a multi-ethnic cohort.
A hypothesis-driven approach over three decades enabled quantiﬁ-
cation and validation of a chronic emotional stress phenotype (Filed:
Provisional RSA patent application number: 2019/05103). The pheno-
type revealed good discriminatory ability with a positive prediction of
cerebro-cardiovascular disease risk in a prospective cohort, independent
of age, ethnicity or sex [Area under the receiver operating characteristic
curve: 0.77 (P  0.001); 85% sensitivity]. The phenotype was deter-
mined with standardized methods (Malan et al., 2015, 2016a, 2017a,
2017b) and applied for the ﬁrst time to expand knowledge on brain,
behavior and immunity function in humans.
2. Materials and methods
2.1. Design and participants
A teachers’ cohort (20–65 years) from the Sympathetic activity and
Ambulatory Blood Pressure in Africans (SABPA) prospective study was
followed for 3 years (Fig. 2), and the study is well-described elsewhere
(Malan et al., 2015). The rationale for the selection of the participants
was to obtain a sample from a homogenous working environment with
similar socio-economic status. Seasonal changes were avoided and
extensive clinical assessments were to be performed in a well-controlled
temperature and light setting. Exclusion criteria were pregnancy, lacta-
tion, tympanum temperature above 37.5 C, the use of psychotropic
substances or α- and β-blockers and blood donors or individuals vacci-
nated within 3 months prior to data collection.
Only teachers participating in both phases (N ¼ 359) were included
for the current investigation. Participants were fully informed about the
objectives and procedures prior to recruitment and provided written,
informed consent. The study conformed to the Helsinki Declaration
(2004) and was approved by The Ethics Review Board of the North-West
University, South Africa: Approval number NWU-0003607S6.
2.2. Cardiovascular measurements
A combined ambulatory blood pressure-electrocardiogram apparatus
(Cardiotens CE120®, Meditech, Budapest Hungary) was applied between
07:00–09:00 onworking days (Monday-Thursday) at the teachers’ school
Fig. 1. Representation of retinal-glia vascular communication in the human adult retina. Light direction is from the bottom to the top. The inner blood retinal barrier
contains: NFL, optic nerve ﬁber layer; ON, optic nerve; GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer with
Horizontal cells (H), Bipolar cell dendrites (B), Microglia (Mi); Astrocytes (As); Amacrine cells (A), Müller cells (M). Stress hormones receptors (alpha2a-adrenergic,
α2a-AR), glucocorticoid (GCR) and dopamine2 (D2R) are expressed in Müller and Amacrine cells. S100B and glial-ﬁbrillary-acidic-protein (GFAP) are expressed in
Astrocytes and Müller cells. The outer blood retinal barrier contains: ONL, outer nuclear layer with rods (R) and cones (C); OS; outer segment layers; PE, pigment
epithelium; Ch, choroid (Drawn by Louise Malan).
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of employment. The blood pressure cuff was ﬁtted to the non-dominant
arms using an appropriate cuff size. Blood pressure measures were ob-
tained every 30 min during the day (08:00–22:00) and hourly during the
night (22:00–06:00). Participants continued their usual daily activities
and were asked to record occurrences of stress, physical activity, head-
ache, syncope, dizziness, nausea, palpitations, hot ﬂushes and visual
disturbances on their ambulatory diary card. The 24 h successful inﬂation
rate was 77.9% (12.9) in Stressed individuals and 81.8% (10.1) in no-
Stressed individuals. The data were analyzed with the CardioVisions 1.19
Personal Edition software (Meditech, Budapest, Hungary). Hypertensive
status was classiﬁed as 24 h SBP 130 mm Hg and/or DBP 80 mm Hg
(Piepoli et al., 2016).Participants resumed their normal school and
extra-curricular activities till 15:00 and hereafter transported to the
North-West University for clinical measures including retinal vessel im-
aging and depression status evaluation under supervision of clinical
psychologists. They fasted from 22:00 till 07:00 when anthropometric
measures as well as blood samples were collected followed by carotid
intima media screening and physical activity measures.
2.3. Retinal vessel analyses (RVA)
Participants abstained from food or caffeine containing beverages,
alcohol, smoking or exercise 1 h prior to measurements. Participants
were introduced to the procedure by a trained registered nurse and
screened for acute anterior angle chamber glaucoma risk with a small
light source. Mydriasis was induced in the right eye of the participant by
means of a drop containing tropicamide, 1% and benzalkonium chloride
0.01% (m/v). Fundus imaging was performed in a well-controlled light
and temperature regulated room with the retinal vessel analyzer with a
Zeiss FF450Plus camera and the software VesselMap 2, Version 3.02
(Imedos Systems GmbH, Jena, Germany). Retinal vessel calibers were
measured as monochrome images by manually selecting ﬁrst order vessel
branches in a measuring zone located between 0.5 and 1.0 optic disc
diameters from the margin or the optic disc. Upon selection of the vessel,
software automatically delineated the vessels’ measuring area. A color
image was used as reference to ascertain correct identiﬁcation of arteries
and veins and two experienced scientists agreed on the vessel type before
selection. Automated software calculations, based on the Knudtson for-
mula, determined estimates from the 6 largest arteries and veins. As the
image scale of each eye was unknown, the values of the retinal arteries
and veins were expressed as measuring units (MU). 1 MU is equivalent to
1 μm when the dimensions of the eye being examined correspond to
those of the normal Gullstrand eye. Reproducibility was computed for a
randomly selected cohort with a correlation coefﬁcient of 0.84.
2.4. Diastolic ocular perfusion pressure (hypo-perfusion risk)
A local anesthetic drop (Novasine Wander 0.4% Novartis) was
inserted in the right eyes in 99% of all cases to measure intra-ocular
pressure (IOP) with the Tono-Pen Avia Applanation Tonometer (Reich-
ert 7–0908, ISO 9001, New York, USA). Right eye diastolic-ocular
perfusion-pressure (mmHg) was calculated (DBP minus intra-ocular
pressure) and hypertensive/diabetic retinopathy was diagnosed by a
registered ophthalmologist.
2.5. Depression
The severity of depressive symptoms was assessed with the Patient
Health Questionnaire (PHQ-9), which contains 9 items and has been
validated in various ethnic groups for use in primary health care settings
(Kroenke and Spitzer, 2002). Each item evaluates the presence of one of
the nine Diagnostic and Statistical Manual of Mental Disorder Fourth
Edition (DSM-IV) criteria for depression. The Cronbach’s alpha-reliability
index for the total PHQ-9 score in the current cohort was 0.80 indicating
good reliability. Moderate-to-severe depressed (PHQ-9 score  10) and
severe depressed cases (PHQ-9 score 15) are clinically relevant.
2.6. Anthropometric measures
Registered level II anthropometrists measured waist circumference to
indicate central obesity (Hoebel et al., 2014) in triplicate with a
non-extensible and ﬂexible anthropometric tape with intra- and inter
variability less than 5%. Total energy expenditure (kCal) over 7 days was
derived from the Actiheart accelerometer (GB06/67703; CamNtech Ltd,
Upper Pendrill Court, Papworth Everard, Cambridgeshire, CB233UY,
UK).
2.7. Carotid intima media thickness
High resolution ultrasound images were acquired from at least two
Fig. 2. The Sympathetic activity and Ambulatory Blood Pressure in African (SABPA) prospective cohort stratiﬁed into Stress and no-Stress phenotype groups.
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optimum angles of the common carotid artery segments [Sonosite
Micromaxx ultrasound system (SonoSite Inc., Bothell, WA, USA) and
6–13 MHz linear array transducer] using the Rudy Meijer protocol. The
images were digitized and imported into the Artery Measurement Sys-
tems automated software (AMS) II v1.139 (Gothenburg, Sweden) for
dedicated analysis of the carotid artery as ischemic stroke risk marker
(Piepoli et al., 2016). For the purpose of this study, the left far wall
measurements were used to estimate left far wall carotid intima media
thickness (L-CIMTf). Carotid bifurcation stenosis was determined at
follow-up by a registered sonar technologist and added as covariate in
retinal models. Intra-observer variability was 0.04 mm between two
measurements made 4 weeks apart on 10 participants.
2.8. Biochemical analyses
Participants were in a semi-recumbent position for at least 30 min
before 09:00 in both study phases. A registered nurse obtained fasting
blood samples from the antebrachial vein branches of the dominant arm
of each participant with a winged infusion set and she also performed
pre- and post-counselling for HIV positive status participants. All blood
samples were handled according to standardized procedures and stored
at 80 C until analyses. All biochemical analyses were done in
duplicate on never thawed serum/plasma samples. Serum lipids were
analyzed with an enzyme rated method (Unicel DXC 800 - Beckman and
Coulter, Germany). Serum gamma glutamyl transferase (GGT) and
whole blood EDTA glycated hemoglobin (HbA1C) were analyzed with
turbidimetric inhibition immunoassays (Cobas Integra 400 Plus,
ROCHE Basel, Switzerland). The American Diabetes Foundation
guidelines were used to deﬁne diabetic status (HbA1C  6.5%). HIV
positive status was determined with a rapid antibody test in plasma
(First response kit. PMCMedical, Daman, India) and conﬁrmed with the
Pareekshak test (BHAT Bio-Tech, Bangalore, India). Serum S100B was
analyzed with an electrochemiluminescence immunoassay (e411,
ROCHE, Basel, Switzerland) with intra- and inter-assay coefﬁcients of
less than 5%.
DuoSet ELISA kits (Catalogue #DY2594-05) from R&D Systems Inc.
(Minneapolis, USA) were used for serum Human GFAP analyses with low
intra- (3.96%) and inter-assay (1.63%) variation. Serum cotinine and
TNF-α were analyzed at an accredited pathology laboratory (AMPATH,
Gauteng, South Africa). Serum cotinine values were derived from a ho-
mogeneous immunoassay (Modular ROCHE Automized systems, Basel,
Switzerland) and serum TNF-α values from a quantikine high sensitivity
human TNF-α enzyme-linked immunosorbent assay (HS ELISA; R&D
Systems, Minneapolis, MN USA). The inter- and intra-assay variability for
TNF-α was 15% and 17.8%, respectively.
2.9. Statistical analyses
Statistica version 13.3 (TIBCO Software Inc., Palo Alto, USA, 2018)
was used for data analyses. A chronic emotional stress phenotype was
used to stratify the cohort into Stress (n ¼ 236) and no-Stress (n ¼ 123)
groups. Normal distribution was computed and skewed data were log-
transformed. Independent T tests compared Stress vs. no-Stress groups
whilst proportions and prevalence were determined by using chi-square
(χ2) statistics. Effect sizes when comparing means are reported as d-
values with 0.2¼ small effect, 0.5¼medium effect and 0.8¼ large effect.
When reporting beta-coefﬁcients or OR as an effect size, the following
guideline values were used: 1.5 ¼ small effect, 2.5 ¼ medium effect and
4.25¼ large effect. Mean changes over 3yrs of each variable within Stress
and no-Stress groups and also in 10 deceased cases were calculated using
dependent sample t-tests. McNemar’s case-control tests were computed
to determine incidence and recovery frequencies over 3 yrs. Retinal
vessel calibers and diastolic-ocular-perfusion-pressure differences were
compared between Stressed vs. no-Stressed groups using single one-way
ANCOVA’s, considering age and the vessel type.
Multiple linear regression analyses determined associations between
retinal vessel diameters, glia and perfusion risk markers in the Stress and
no-Stress groups. Baseline a-priori selected covariates were age, waist
circumference, cotinine, GGT, HbA1c, total chol:HDL, TNF-α, as well as
carotid bifurcation stenosis, hypertensive/diabetic retinopathy and
diastolic-ocular-perfusion-pressure obtained at follow-up. When the
retinal artery was a dependent variable, the retinal venous diameter was
included as covariate and vice versa. Dependent variables included
retinal artery and -venous vessel calibers. Independent covariates
included a-priori selected covariates delineated above and glia cell risk
markers in separate models. Model 1: included baseline S100B and/or
GFAP or GFAP:S100B; Model 2 included follow-up S100B and/or GFAP
or GFAP:S100B; and Model 3 included 3-yr changes in S100B and/or
GFAP or GFAP:S100B. Three year percentage changes (Δ) were calcu-
lated as follows: 3yr follow-up – baseline/baseline x 100.
In sensitivity analyses:
a) Regression analyses were repeated to consider HIV positive status; as
well as moderately severe depression (PHQ-9 score >10).
b) We stratiﬁed the chronic emotional stress phenotype into three
equally sized groups after ordering the values from smallest to largest
in order to more ﬁnely differentiate the stressed participants (no
Stress; mildly Stressed and very Stressed). Statistical analyses were
repeated to detect changes in glial and retinopathy risk markers over
3 years using dependent samples T tests. Linear regression analyses
followed to assess associations between retinal vessel changes and
risk markers in the three groups. The dependent variables included
retinal artery and -venous vessel calibers; and the independent
covariates included a-priori selected covariates.
The statistical signiﬁcance level was set at p  0.05 (two-tailed). The
F to enter in regression models was ﬁxed at 2.5.
3. Results
A total of 359 participants with a mean age of 45.6  9.1 years were
followed for 3 years. In Table 1, more men (64%) were classiﬁed of
having chronic stress compared to their female counterparts (36%).
A higher mortality count was observed in Stress individuals (n ¼
16; 53  7.3 years) vs. the no-Stress individual who passed away after
a vehicle head on collision (n ¼ 1) (p ¼ 0.02). The higher mortality
count in Stress individuals was caused by various diseases: stroke (N
¼ 2), kidney/heart failure (N ¼ 3), cancer (N ¼ 2), diabetes (N ¼ 4),
coronary disease/event (N ¼ 4), and suicide (N ¼ 1). Stress individuals
had more cardiometabolic perturbations with medium - high effect
sizes (p  0.001) with higher central obesity (d ¼ 0.5, medium effect),
total cholesterol:HDL > 5 and HbA1C (d  0.8, large effect); TNF-α (d
¼ 0.4, moderate effect) and 24 h blood pressure (d ¼ 1, large effect)
than non-Stress individuals. Glial cell risk markers were similar with
small effect sizes in the Stress vs. no-Stress groups, S100B (d ¼ 0.32),
GFAP (d ¼ 0.13) and GFAP:S100B (d ¼ 0.12). The Stress vs. no-Stress
group showed higher diastolic-ocular-perfusion-pressure (d ¼ 0.8,
large effect) and narrower arteries (d ¼ 0.5, medium effect); higher
prevalence for 24 h hypertension (75% vs. 16%); diabetes (13% vs.
0%), hypertensive/diabetic retinopathy (57% vs. 47%), arteriovenous
nicking (48% vs. 32%), and usage of more ACE inhibitors (10% vs.
2%), calcium channel blockers (6% vs. 0%) and thiazides (13% vs.
1%).
Three year changes in glia cell risk markers with respect to the stress
phenotype are shown in Fig. 3.
A similar proﬁle was observed in the Stress death/mortality cases
(Fig. 3a) as in the total Stress cohort (Fig. 3b), namely consistently raised
S100B, TNF-α and HbA1C levels with decreases in GFAP. In Table S1,
consistently raised GGT, SBP and decreases in the GFAP:S100B ratio in
Stressed individuals and in mortality cases were observed. Low incidence
frequencies for hypertension (5%) and diabetes (3%) were apparent with
greater recovery frequencies in hypertension (16%), and almost absent in
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diabetes (1%). In the non-Stressed individuals, metabolic factors TNF-α,
GGT and HbA1C increased over 3-yrs (p < 0.05); with no 3yr frequency
variance in either hypertensive or diabetic status.
In Fig. 4, retinal calibers and diastolic-ocular-perfusion-pressure are
presented adjusting for age and artery/venous vessel diameter. Arterial
narrowing, venous widening and diastolic-ocular-perfusion-pressure
levels were signiﬁcantly higher (p  0.001) in the Stress vs. the non-
Stress group.
Unadjusted regression analyses showed associations between mor-
tality (N ¼ 10), consistent S100B (r ¼ 0.11; p ¼ 0.042) and down-
regulation in GFAP (r ¼ 0.152; p ¼ 0.004) (data not shown). Linear
regression associations in the Stress group (Table 2) emerged between
retinal artery narrowing, higher diastolic-ocular-perfusion-pressure,
consistent S100B and GGT [Adj. R2 0.39, p  0.05]; with small-
medium effect.
Venous widening was associated with higher diastolic-ocular-
perfusion-pressure, consistent S100B (p  0.001), ΔGFAP:S100B de-
creases (p ¼ 0.060); persistent GGT and TNF-α levels [Adj. R2 0.35–0.41,
p  0.05]; with small-medium effect. Retinal-glia associations did not
change when considering HIV positive status; or when repeating the
analyses in moderately-severe depressed cases (PHQ-9 10; N¼ 69). No
retinal-glia associations were evident in non-Stressed individuals.
Furthermore, changes over 3-yrs in glial and retinopathy risk markers
and mortality rates increased linearly across the mildly and very Stressed
groups (Table S2); with the highest risks consistently observed in the
Stress phenotype group. Similarly, associations between artery narrow-
ing and venous widening (Table S3) in the mildly and very Stressed
groups corroborated ﬁndings shown for the Stress phenotype group.
4. Discussion
A chronic stress phenotype independent of age, ethnicity or sex re-
ﬂected ongoing retinal-glia ischemia with consistently raised hyperten-
sion, S100B-immune responsivity and decreases in GFAP, retinal arterial
narrowing and -venous widening. All retinal-glia cell associations
showed small-to-moderate effects, suggesting clinical relevance for
ischemic stroke risk.
Interestingly, retinal-glia ischemia afﬂicted more men (64%) whilst
women appeared to be more resilient (no-Stress group, 72%). Contra-
dictory ﬁndings from Stegenga et al. (2012) rather suggested a higher
physiological vulnerability in depressed women than in their male
counterparts. Whether depression affects men and women similarly is
disputable as depressed patients, independent of sex, had diminished
gray matter volumes and reduced astrocyte densities in the hippocampus
and prefrontal cortex (Krishnan and Nestler, 2008). Contrastingly pre-
vious ﬁndings (Du and Pang, 2015) did not show any relationship
Table 1
Comparing the clinical characteristics of the chronic emotional stress phenotype cohort (Stress vs. no-Stress).
Stress (n ¼ 236) no-Stress (n ¼ 123) P-values d-values
Age (years) 46.3 (8.9) 44.3 (9.0) 0.047 0.22
Black/Whites, n (%) 129/107 (55/45) 44/79 (36/64)
Men, n (%) 150 (64) 30 (24) <0.001 0.78
Physical activity (kCal/7 days) 3394.1 (1513.1) 3199.5 (1099.0) 0.210 0.14
Retinal-glia risk markers
Cotinine (ng/ml) 0.01 (0.01, 0.01) 0.01 (0.01, 0.01) 0.128 0.17
Gamma glutamyl transferase (U/l) 33.6 (21.0, 61.4) 20.0 (12.0, 37.8) <0.001 0.32
Waist circumference (cm) 98.2 (88.7, 106.3) 83.3 (74.6, 93.4) <0.001 0.89
Total cholesterol:HDL 5.2 (2.0) 3.9 (1.1) <0.001 0.75
HbA1c (%) 6.0 (1.1) 5.5 (0.3) <0.001 1.35
Tumor necrosis factor-α (pg/ml) 2.5 (1.1, 4.2) 1.4 (0.1, 2.8) 0.047 0.41
24 h SBP (mmHg) 134 (15) 118 (8) <0.001 1.07
24 h DBP (mmHg) 84 (10) 73 (6) <0.001 1.10
Intra-ocular pressure (mmHg) 16 (4) 15 (4) 0.044 0.26
Diastolic-ocular-perfusion-pressure (mmHg) 73 (12) 64 (10) <0.001 0.78
S100B (μg/L) 0.05 (0.0) 0.04 (0.0) 0.421 0.33
S100B (μg/L) 0.04 (0.03, 0.06) 0.04 (0.03, 0.05)
GFAP (ng/ml) 29.1 (52.3) 36.5 (61.0) 0.232 0.13
GFAP (ng/ml) 1.39 (0.2, 31.7) 2.28 (0.2, 48.7)
GFAP:S100B 815.92 (1580.5) 1013.30 (1741.0) 0.281 0.12
GFAP:S100B 25.3 (4.5, 938.8) 57.2 (5.0, 1397.0)
Retinal arterial caliber (MU) 148.5 (11.1) 154.1 (13.4) <0.001 0.46
Retinal venous caliber (MU) 243.2 (20.0) 240.6 (20.2) 0.267 0.13
Retinopathy, n (%) 134 (57) 55 (45) 0.024 0.24
Retinal arteriovenous nicking, n (%) 110 (48) 38 (32) 0.004 0.32
Optic nerve head damage 21 (9) 8 (7) 0.430 0.09
Moderate-to-severe depression (PHQ-9  10), n (%) 69 (29) 40 (33) 0.521 0.07
Severe depression (PHQ-9  15), n (%) 26 (11) 15 (12) 0.739 0.04
Left-CIMTf  0.75 mm, n (%) 79 (34) 18 (15) <0.001 0.42
24 h Hypertension, n (%) 176 (75) 19 (16) <0.001 1.19
Diabetes 30 (13) 0 (0) <0.001 0.46
Medications
Anti-depressants 2 (1) 2 (2) 0.505 0.07
ACE-inhibitors 23 (10) 2 (2) 0.004 0.32
Aspirin 13 (6) 3 (2) 0.181 0.15
Beta-blockers 6 (3) 1 (1) 0.261 0.13
Calcium channel blockers 14 (6) 0 (0) 0.006 0.31
Diuretics 31 (13) 1 (1) 0.001 0.43
Statins 8 (3) 3 (2) 0.620 0.06
Values are presented as mean (SD) and/or median ( 95% interquartile range). Abbreviations: HbA1C, glycated hemoglobin; GFAP, glial-ﬁbrillary-acidic-protein;
Moderate-severe depression, Patient Health Questionnaire-9/PHQ-9 and Severe depression, PHQ-915 (Kroenke and Spitzer, 2002); Optic nerve head damage,
cup-to-disc ratio  0.3 plus intra-ocular pressure 21 mmHg; 24h Hypertension, SBP  130 and/or DBP  80 mmHg and L-CIMTf, left-carotid intima media thickness
far wall  0.75 mm (Piepoli et al., 2016); Diabetes (HbA1C, glycated hemoglobin  6.5 %, American Diabetes Association). Cohen’s d-values reﬂected as: 0.2 ¼ small
effect, 0.5 ¼ medium effect and 0.8 ¼large effect.
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between depression and cerebrovascular risk markers. Currently only the
Stress phenotype reﬂected consistently raised S100B and decreased
GFAP as markers of stress-related ongoing ischemia. The stress pheno-
type (quantitative markers) appears to be superior to a qualitative score
for depression (e.g. PHQ-9); as moderately-depressed (PHQ-9 10) cases
did not reveal retinal-glia ischemia risk.
4.1. Chronic stress; glia ischemia and inﬂammatory responsiveness
Glia-ischemia (Wheelock et al., 2016) in the Stress group was re-
ﬂected by chronically raised S100B and downregulation of GFAP with
persistently raised inﬂammatory markers (TNF-α). Decreases in brain
GFAP might be a consequence of astrocyte pathology in limbic cortex
areas in depressed/suicide cases (Sild et al., 2017). In rodent models,
hippocampal (ventral subiculum) lesions during prolonged stress were
accompanied by diminished glucocorticoid-immunoreactivity respon-
sivity (Jauregui-Huerta et al., 2010). Chronic stress may not actually
reduce astrocyte numbers but instead could selectively decrease GFAP
(Tynan et al., 2013). Stress-induced astrocyte-mediated disturbances
may not be due to a loss of cells but rather a consequence of potential
changes in synaptic function or even altered receptor function. These
changes can indeed facilitate astrocyte and particularly microglia release
of gliotransmitters, such as cytokine TNF-α (Stellwagen and Malenka,
2006) as observed in the Stress group; and which may disturb neuro-
vascular communication in the inner blood-retinal-barrier. Serum TNF-α
may translate to brain TNF-α as peripheral TNF-α regulated immune cell
trafﬁcking in the mouse brain (Paouri et al., 2017), which support our
ﬁndings of retinal vein widening and associated serum TNF-α responses,
reﬂecting endothelial dysfunction (Liew and Wang, 2011). Venous
widening in the Stress group, was related to inﬂammatory responsivity
Fig. 3. Presenting changes in retinal-glia risk markers over a period of 3-years in deceased cases from the Stress group (Fig. 3a); and in the total stress cohort (Fig. 3b).
Individuals participated at both phases.
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and GFAP:S100B decreases, suggestive of GFAP decreases which can
reduce activity of GFAP-positive astrocytes (Someya et al., 2019). The
stress-induced ongoing ischemia or persistent S100B release will impair
myogenic control and increase vascular resistance and -tone (arterial
narrowing) (Liew and Wang, 2011; Someya et al., 2019) with potential
damage to the retinal ganglion cells and optic nerve head.
Indeed, the similar nature of glia cell signaling in the retina and brain
suggests similar neuron and glia-blood vessel or neurovascular commu-
nication (Someya et al., 2019; Wentzel et al., 2019). Ischemic stroke risk
increases as both carotid intima media thickening and retinal arterial
occlusion risk is apparent (Piepoli et al., 2016; Someya et al., 2019;
Wentzel et al., 2019; Wu et al., 2017; Malan et al., 2016b) in the Stress
group (retinal artery narrowing, venous widening and arteriovenous
nicking).
A proﬁle of disturbed neurovascular communication is emerging in
the Stress group with ongoing glia ischemia and a composite proﬁle of
ocular perfusion deﬁcits, persistent inﬂammatory responsivity and
alcohol abuse or higher GGT levels. Even though GGT levels have also
been linked to oxidative stress status and fatty liver disease, higher GGT
is a key mechanism by which excessive ethanol consumption promotes
tissue injury and inﬂammatory responsiveness in the brain (Enh€orning
and Malan, 2019). Zong et al. (2010) indeed suggested that S100B
release and GFAP expression, contributed to inﬂammation-linked re-
sponses in retinal neurons. Consistent inﬂammatory responsivity in the
Stress group supports the notion of heightened immune function during
chronic emotional “uncontrollable” stress (Wetherell et al., 2017) and
hypo-activity in the HPAA (Du and Pang, 2015). Inﬂammatory respon-
sivity and associated hypertension (Piepoli et al., 2016) with higher
diastolic-ocular-perfusion-pressure in stressed individuals could there-
fore reﬂect a maladaptive mechanism to compensate for reduced blood
perfusion (hypo-perfusion) in the inner blood-retina-barrier.
4.2. Chronis stress, ischemia and hyperglycemia
Susceptibility for artery occlusion and ischemic stroke risk further
seems to increase in the Stress group; considering hypo-perfusion and
chronic hyperglycemia, which may increase brain insulin-signaling
dysfunction and risk for diabetic retinopathy (Díaz-Coranguez et al.,
2017). Brain-endothelium insulin receptors may dysregulate kinetics in
insulin delivery and neural tissues (Barber et al., 2000). Moreover artery
narrowing, venous widening and higher prevalence of arteriovenous
nicking in the Stress group suggest diminished vascular tone as glia
cell-mediated vasodilation may be reduced (Mathea and Newman, 2006;
Kotliar et al., 2017).A prolonged retrograde propagation of the vascular
response has indeed been associated with endothelial dysfunction and
retinal venous widening (Ito et al., 2003). Chronic hyperglycemia in the
Stressed group may partially explain altered metabolic capacity and a
reduced ability to maintain blood-retinal-barrier homeostasis in endo-
thelial cells (Dada, 2017) with decreases or downregulation of astrocyte
GFAP expression.
The ongoing ischemia in the Stress group reﬂected consistently raised
S100B levels, which increases metabolic demands and higher blood ﬂow
or hyperemia (cerebral and retina) to maintain perfusion pressure (Chen
and Swanson, 2003). Hyperemia may act as a short-term protective
mechanism against pathological conditions. Chronic hyperemia may
however be detrimental as the increases in blood ﬂow far exceed the
increasing metabolic demand of glia cells and neurons (Mathea and
Newman, 2006; Ding et al., 2013) potentially increasing
inﬂammation-driven endothelial dysfunction in the inner
blood-retinal-barrier. Future risk for artery occlusion and ischemic stroke
may therefore activate downstream signaling pathways and increase the
risk for stress-related vascular and neurodegenerative diseases.
4.3. Potential mechanism for retinal-glia ischemia and stroke risk
The ﬁndings of our study suggest a potential pathway where chronic
stress facilitates ongoing ischemia with astrocyte S100B release and
consistent higher or upregulated TNF-α released by microglia. This may
occur via engagement of the immune-globulin transmembrane protein
receptor for advanced-glycation-end-products (RAGE) (Díaz-Coranguez
et al., 2017). Ongoing ischemia and RAGE-mediated transcytosis exem-
plify endothelial dysfunction (venous widening) and chronic hypergly-
cemia in the Stress group. A compensatory mechanism or high pressure
system can be directly detected by astrocytes, microglia or Müller cells
via reactive astrogliosis in an attempt to restore homeostasis in the inner
blood-retinal-barrier. Monoamine depletion due to stress may further
trigger RAGE activity (Ding et al., 2013) thereby inducing astrocyte
calcium waves and altering astrocyte function. Stress-hormone receptors
Fig. 4. Comparing (mean  SE) retinal vessel caliber diameters and diastolic-ocular-perfusion-pressure independent of age in Stressed vs no-Stressed individuals.
When the retinal artery was a dependent variable, the retinal vein was included as covariate and vice versa.
L. Malan et al. Brain, Behavior, & Immunity - Health xxx (xxxx) xxx
7
(e.g. glucocorticoid and norepinephrine) are located on the surface of
astrocytes (Ding et al., 2013; Chandley et al., 2012); and dysfunctional
stress-hormone levels were indeed associated with retinal vascular dys-
regulation in the SABPA cohort, independent of ethnicity and sex [under
review].
The current study is limited by its sample size as larger cohorts are
needed to more representatively verify ongoing retinal-glia ischemia. In
addition, a more comprehensive proﬁle of glia cell markers should be
assessed to provide evidence for stress-related glia pathology in the
inner-blood-retinal barrier. Associations between mortality risk,
increasing S100B and GFAP downregulation should be further investi-
gated and validated. Strengths of the study include the application of a
novel quantiﬁed chronic emotional stress phenotype to assess progres-
sion of retinal-glia ischemia using gold standard measures and a well-
controlled protocol.
In conclusion, chronic stress reﬂected retinal-glia ischemia and stroke
risk. Persistent higher S100B but GFAP decreases related to ﬁndings of
stress-induced astrocyte pathology in the human retina.
4.4. Translational clinical value
Stress may play an important role in the pathogenesis of synaptic
plasticity as ischemic conditions alter neurotrophic signaling, synaptic
plasticity and pathophysiology. A validated Stress phenotype was
applied and enabled detection of ischemic stroke susceptibility in the
brain-retina axis. Preventive screening for Stress is recommended as it
may improve individual awareness on stress-related ischemic stroke risk.
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